People · Operator
Named in public records as an officer, director or promoter · active 2013–2021 · Pharmaceuticals, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Phosplatin Therapeutics LLC | — | Pharmaceuticals | Series B | $72.3M | $722.8M | 2021 |
| Y-Prime, Inc. | — | Other Technology | Series A | $11.6M | $57.3M | 2013 |
Elizabeth Tallett at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Elizabeth Tallett on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Walker | 1 | 16 |
| Paul Blake | 1 | 10 |
| SEAN BARKMAN | 1 | 5 |
| John Porter | 1 | 4 |
| Matthew Price | 1 | 4 |
| Travis Milks | 1 | 3 |
| Matthew Rice | 1 | 3 |
| Neil Sunderland | 1 | 2 |
| PETER ESPIG | 1 | 2 |
| Richard Gastineau | 1 | 2 |
| MARK MAIETTA | 1 | 1 |
| Shawn Blackburn | 1 | 1 |
| Vlad Tinovsky | 1 | 1 |
| Jaime Cook | 1 | 1 |
| Rosita Leong | 1 | 1 |
| Robert Fallon | 1 | 1 |
| John Caouette | 1 | 1 |
| Frances Bonham | 1 | 1 |
| Charles Stuckey | 1 | 1 |
| Fallon Robert | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.